urapidil has been researched along with Dermatitis Medicamentosa in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igawa, K; Satoh, T; Takehara, Y; Yokozeki, H | 1 |
1 other study(ies) available for urapidil and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Psoriasiform eruption induced by alpha1-adrenergic blocker, urapidil.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Eruptions; Erythema; Humans; Male; Piperazines; Prostatic Hyperplasia; Psoriasis | 2007 |